Table 12 Agreement between PET/CT and BMB in NHL cases
From: PET/CT and bone marrow biopsy (BMB) in evaluating bone marrow in lymphoma
| Â | Â | BMB | Total | ||
|---|---|---|---|---|---|
Negative | Positive | Â | |||
PET/CT | Negative | Count | 29 | 1 | 30 |
% of total | 50.9% | 1.8% | 52.6% | ||
Positive | Count | 13 | 14 | 27 | |
% of total | 22.8% | 24.6% | 47.4% | ||
Total | Â | Count | 42 | 15 | 57 |
% of total | 73.7% | 26.3% | 100.0% | ||